Lynparza
Active substance: olaparib
TABLET, FILM COATED · OLAPARIB 150 mg/1
United StatesActive
Marketing holder: AstraZeneca Pharmaceuticals LP
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- OLAPARIB · 150 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-7114-76d3-a8f4-a55171972117,01a12094-293e-70bf-a3a3-8c6cc1878354,01a1209b-8ab4-79f8-9cd8-ddb5a986ede8,01a1209d-d8eb-7c13-8e2f-c4f991448567;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0310-0679
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0310-0679 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0310-0679 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0310-0679 · Verified 2026-10-09 · open in source